Meratrim® is a proprietary blend of two plant extracts, Sphaeranthus indicus flower heads and Garcinia mangostana fruit rind. Each plant contributes an essential part to Meratrim’s ability to affect multiple pathways involved in fat cell formation and breakdown for ultimate weight management benefits. Meratrim was shown in two randomized, double-blind, placebo-controlled clinical studies to significantly reduce weight and waist size in two weeks and to significantly reduce hip size in eight weeks.
CLINICAL RESEARCH DEMONSTRATES REDUCTION IN WEIGHT, WAIST AND HIP SIZE
Two randomized, double-blind, placebo-controlled research studies have demonstrated that 400mg of Meratrim® taken twice a day significantly reduced body weight and waist and hip size better than diet and exercise alone in overweight subjects at eight weeks. A Statistical analysis was performed on the combined results from the first and an additional double-blind placebo controlled study which also demonstrated significant benefits for weight loss, BMI, waist and hip circumference compared to placebo at two and eight weeks.
REDUCES WAIST AND HIP AREAS
Excess body fat is typically stored in the waist and hip areas. Meratrim has been clinically shown to reduce inches off these particular areas, helping to slim the stomach and hips when combined with a 2,000 calorie diet and moderate walking exercise 5 days per week. Meratrim’s clinically demonstrated ability to ultimately reduce hip and waist size may be due to its ability to significantly increase the, adiponectin levels, a hormone linked to lipid metabolism. Preliminary in-vitro data demonstrates Meratrim’s ability to reduce the expression of several key biomarkers involved in the creation, growth and storage of fat cells. Based on these findings, it can be inferred that the success of Meratrim in reducing weight over and above the results experienced by those dieting and exercising alone, may be related to these mechanisms.
CLINICALLY DEMONSTRATED SAFETY
Meratrim is derived from plants traditionally used in Southeastern Asian culture. Clinical research demonstrates no side effects attributed to the blend. A comprehensive safety profile on Meratrim, including a 90-day broad spectrum safety evaluation, indicates no adverse effects.